Lung Cancer

November 11, 2015November 11, 2015

AstraZeneca’s Therapy Aids Lung Cancer Patients with Rare Complication

Lung Cancer, News

Results from the Phase I BLOOM clinical trial revealed that AstraZeneca’s AZD9291 offer encouraging activity in heavily pretreated non-small cell lung cancer (NSCLC) patients with leptomeningeal disease. The data was presented ... Read more

November 10, 2015November 10, 2015

Lung Cancer Patients’ Long-term Survival Linked to Protein’s Presence

Lung Cancer, News

A new research study shows a direct correlation between loss of a tumor suppressor protein expression in a cancer tumor and patients’ long-term survival after chemotherapy. The research paper, entitled “Loss of ... Read more

November 4, 2015November 4, 2015

Lung Cancer Research Foundation Grants $2.1M to Research

Lung Cancer, News

The Lung Cancer Research Foundation (LCRF) has awarded a record total of $2.1 million to advance research related to lung cancer. The 2015 Scientific Grant Program awards were officially presented to 28 research ... Read more

November 3, 2015November 3, 2015

Aggressive Lung Cancer Linked to Mutations in EphA2 Enzyme

Lung Cancer, News

In a recent study published in the journal Proceedings of the National Academy of Sciences, a team of researchers from the Salk Institute have discovered that a mutated enzyme, called ... Read more

November 2, 2015November 2, 2015

MOLOGEN AG Achieves Patient Enrollment Goal for Small Cell Lung Cancer IMPULSE Study with Developmental Drug MGN1703

Lung Cancer, News

MOLOGEN AG, a biotechnology company focused on the development of cancer and infectious disease immunotherapies, has announced that its IMPULSE lung cancer clinical study has achieved its recruitment goal of ... Read more

November 2, 2015November 2, 2015

Results in Fruquintinib Proof-of-Concept Phase II Clinical Trial for Non-Squamous NSCLC Show Promise

Lung Cancer, News

Pharmaceutical company Hutchison China MediTech Limited (Chi-Med) recently announced that its R&D drug subsidiary Hutchison MediPharma Limited (HMP) will receive a $10 million dollar milestone payment from its partner Eli Lilly and Company ... Read more

October 29, 2015October 29, 2015

Merck’s NSCLC Drug Keytruda Outperforms Established Chemotherapy Drug

Lung Cancer, News

Merck recently announced topline data from the KEYNOTE-010 clinical trial assessing pembrolizumab as a treatment for patients with advanced non-small-cell lung cancer (NSCLC), determining that the study met its initial endpoint. Pembrolizumab (formerly MK-3475 and lambrolizumab, ... Read more

October 29, 2015October 29, 2015

Lung Cancer Cells Killed With ‘Protein Cage’ Carrying Anti-cancer Drug

Lung Cancer, News

Researchers from Washington State University have developed a drug-delivery system consisting of a protein vesicle — a kind of “protein cage” — encapsulating an anti-cancer drug. This novel system achieved direct, targeted, ... Read more

October 23, 2015October 23, 2015

Lung Tumors’ Spread Limited by Patrolling Monocytes in Study

Lung Cancer, News

The immune system has safeguarding mechanisms that identify and degrade harmful cells and cellular debris. Patrolling monocytes, a subpopulation of circulating white blood cells, is one type of immune cell serving as ... Read more

October 22, 2015October 22, 2015

Synta Ceases Phase 3 GALAXY-2 Trial in Patients with Advanced Non-small Cell Lung Adenocarcinoma

Lung Cancer, News

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on research, development and commercialization of novel oncology medicines, recently announced that the company has decided to cease its Phase 3 GALAXY-2 trial of docetaxel ... Read more